Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants.
In previous work, Salmonella enterica serovar Typhimurium strain SL1344 was exposed to sublethal concentrations of three widely used farm disinfectants in daily serial passages for 7 days in an attempt to investigate possible links between the use of disinfectants and antimicrobial resistance. Stable variants OXCR1, QACFGR2, and TOPR2 were obtained following treatment with an oxidizing compound blend, a quaternary ammonium disinfectant containing formaldehyde and glutaraldehyde, and a tar acid-based disinfectant, respectively. All variants exhibited ca. fourfold-reduced susceptibility to ciprofloxacin, chloramphenicol, tetracycline, and ampicillin. This coincided with reduced levels of outer membrane proteins for all strains and high levels of AcrAB-TolC for OXCR1 and QACFGR2, as demonstrated by two-dimensional high-performance liquid chromatography-mass spectrometry. The protein profiles of OXCR1 and QACFGR2 were similar, but they were different from that of TOPR2. An array of different proteins protecting against oxidants, nitroaromatics, disulfides, and peroxides were overexpressed in all strains. The growth and motility of variants were reduced compared to the growth and motility of the parent strain, the expression of several virulence proteins was altered, and the invasiveness in an enteric epithelial cell line was reduced. The colony morphology of OXCR1 and QACFGR2 was smooth, and both variants exhibited a loss of modal distribution of the lipopolysaccharide O-antigen chain length, favoring the production of short O-antigen chain molecules. Metabolic changes were also detected, suggesting that there was increased protein synthesis and a shift from oxidative phosphorylation to substrate level phosphorylation. In this study, we obtained evidence that farm disinfectants can select for strains with reduced susceptibility to antibiotics, and here we describe changes in protein expression in such strains.
Karatzas
Kimon A G
KA
Division of Veterinary Pathology, Infection and Immunity, School of Clinical Veterinary Science, University of Bristol, Langford House, Langford, Bristol BS40 5DU, United Kingdom. Kimon-Andreas.Karatzas@nuigalway.ie
Randall
Luke P
LP
Webber
Mark
M
Piddock
Laura J V
LJ
Humphrey
Tom J
TJ
Woodward
Martin J
MJ
Coldham
Nick G
NG
D001483:Base Sequence; D002851:Chromatography, High Pressure Liquid; D017931:DNA Primers; D004202:Disinfectants / Q000633:toxicity*; D052978:Disk Diffusion Antimicrobial Tests; D024901:Drug Resistance, Multiple, Bacterial; D016521:Electrophoresis, Gel, Pulsed-Field; D029968:Escherichia coli Proteins / Q000235:genetics; D007700:Kinetics; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D010641:Phenotype; D040901:Proteomics; D012097:Repressor Proteins / Q000235:genetics; D012486:Salmonella typhimurium / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development; D012641:Selection, Genetic; D017422:Sequence Analysis, DNA
C515217:AcrR protein, E coli; D017931:DNA Primers; D004202:Disinfectants; D029968:Escherichia coli Proteins; D012097:Repressor Proteins